An open-label, single-arm, multicenter study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of Alpha-0261 tablets in patients with moderate to severe active ulcerative colitis (UC) (ChiCTR) - Sep 16, 2026 - P=N/A | N=10 | Not yet recruiting | Sponsor: The first affiliated hospital of anhui medical university; The first affiliated hospital of anhui medical university
New trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
|